Get the Stockscreener App
4.40
0.46%
0.02
After Hours:
4.41
0.010
+0.23%
Achieve Life Sciences Inc stock is traded at $4.40, with a volume of 476.66K.
It is up +0.46% in the last 24 hours and up +4.76% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$4.38
Open:
$4.35
24h Volume:
476.66K
Relative Volume:
0.34
Market Cap:
$233.16M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-3.964
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
-1.12%
1M Performance:
+4.76%
6M Performance:
+42.86%
1Y Performance:
+3.53%
1-Day Range:
$4.30
$4.505
1-Week Range:
$4.26
$4.90
52-Week Range:
$1.84
$5.78
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
4.40 | 233.16M | 0 | -32.94M | -24.95M | -1.11 |
|
ARGX
Argen X Se Adr
|
929.61 | 55.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.02 | 110.91B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
197.40 | 41.21B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
376.63 | 40.48B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
704.31 | 72.89B | 14.25B | 4.58B | 3.88B | 41.77 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
Why Achieve Life Sciences Inc. (SP4P) stock gets analyst attentionJuly 2025 Update & Daily Chart Pattern Signals - newser.com
Is Achieve Life Sciences Inc. stock entering bullish territoryMarket Activity Summary & Accurate Entry/Exit Alerts - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock a fit for income portfoliosJuly 2025 Breakouts & Capital Protection Trading Alerts - newser.com
What dividend safety score for Achieve Life Sciences Inc. stockJuly 2025 Setups & Consistent Growth Equity Picks - newser.com
How to recover losses in Achieve Life Sciences Inc. stock2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock nearing a technical breakoutBuy Signal & Weekly Stock Performance Updates - newser.com
Is Achieve Life Sciences Inc. stock near bottom after declineJuly 2025 Setups & Consistent Growth Equity Picks - newser.com
Can Achieve Life Sciences Inc. (SP4P) stock sustain breakout momentum2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Will Achieve Life Sciences Inc. stock continue dividend increasesWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Can Achieve Life Sciences Inc. stock withstand economic slowdownJuly 2025 EndofMonth & Verified Technical Signals - newser.com
How Achieve Life Sciences Inc. (SP4P) stock reacts to monetary easingEarnings Beat & Technical Buy Zone Confirmation - newser.com
Can Achieve Life Sciences Inc. (SP4P) stock retain market dominanceJuly 2025 Retail & Free High Return Stock Watch Alerts - newser.com
Why Achieve Life Sciences Inc. stock could rally in 2025Portfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Can Achieve Life Sciences Inc. (SP4P) stock sustain institutional flowsJuly 2025 Macro Moves & Intraday High Probability Alerts - newser.com
Will Achieve Life Sciences Inc. stock return to pre crisis levelsWeekly Profit Report & Weekly Consistent Profit Watchlists - newser.com
How analysts revise price targets for Achieve Life Sciences Inc. (SP4P) stockJuly 2025 Retail & Smart Allocation Stock Tips - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock a defensive play amid uncertaintyProfit Target & Fast Moving Trade Plans - newser.com
What momentum shifts mean for Achieve Life Sciences Inc.Weekly Risk Report & Safe Capital Preservation Plans - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock included in top ETFs2025 Winners & Losers & Long-Term Growth Plans - newser.com
When is the best time to exit Achieve Life Sciences Inc.2025 Volatility Report & Weekly High Momentum Picks - newser.com
Why Achieve Life Sciences Inc. (SP4P) stock could outperform next yearJuly 2025 Technicals & Verified Momentum Stock Watchlist - newser.com
Real time pattern detection on Achieve Life Sciences Inc. stockProfit Target & Growth Focused Entry Point Reports - newser.com
Can Achieve Life Sciences Inc. stock deliver strong Q4 earningsVolume Spike & Real-Time Volume Analysis Alerts - newser.com
How Achieve Life Sciences Inc. stock valuations compare to rivalsJuly 2025 Fed Impact & Verified Technical Trade Signals - Fundação Cultural do Pará
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.99%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):